How long should older people take antidepressants to prevent relapse?;Por quanto tempo os idosos devem tomar antidepressivos para evitar recaídas?

Revista Brasileira de Psiquiatria

Volumn 24, Issue SUPPL. 1, 2002, Pages 70-73

  Spear, Jon ^a,b  

^a Peel and Rockingham Kwinana Mental Health Service for Older People   (Australia)

^b Peel and Rockingham Kwinana Mental Health Service for Older People   (United States)

Author keywords

Aged; Depression; Primary prevention; Review literature; Therapeutics

Indexed keywords

ANTIDEPRESSANT AGENT; DOXEPIN; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; DEPRESSION; DRUG EFFICACY; HUMAN; MAINTENANCE THERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RELAPSE; REVIEW;

EID: 0036104826     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462002000500013     Document Type: Review

References (38)

1. Review of community prevalence of depression in late life
2. The course of depression in the elderly: A longitudinal community-based study in Australia
3. Global mortality, disability, and the contribution of risk factors: Global burden of disease study
4. Impact of depressive symptoms on hospitalisation risk in community-dwelling older persons
5. Prevalence and course of depression among elderly residential home admissions in Mannheim and Camden, London
6. Efficacy of acute treatment for geriatric depression
7. Antidepressants and the elderly: Double-blind trials 1987-1992
8. Treatment outcome in recurrent major depression: A post-hoc comparison of elderly ("young old") and mid-life patients
9. How common is resistance to treatment in recurrent, non-psychotic geriatric depression?
10. Use of SSRIs in "very old" depressed nursing home residents
11. The prognosis of depression in the elderly
12. The prognosis of depression in old age: Good, bad or indifferent?
13. How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin
14. Recovery and relapse from major depression in the elderly
15. Three-year prognosis of depression in the community-dwelling elderly
16. Factors associated with recovery and recurrence of depression in older people: A prospective study
17. Outcome of the depressed elderly living in the community in Liverpool: A 5-year follow up
18. The natural history of depression and the anxiety disorders in older people: The Islington community study
19. Prognosis of depression in the elderly a comparison with younger patients
20. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients
21. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression
22. The effect of treatment on two-year course of late-life depression
23. Maintenance treatment for recurrent depression in late life
24. A rating scale for depression
25. Natural history of pharmacotherapy of older depressed community residents. The MRC-ALPHA Study
26. The outcome of depression and dysthymia in a very elderly population: Results form a three-year follow-up study
27. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: A retrospective analysis over 15 years
28. A randomised controlled trial of the effect of intervention by a psychogeriatric team on depression of frail elderly people at home
29. Approaches to the management of depression in old age
30. Protection from clinical depression in medical long-term care facilities: Evidence for psychological adaptation in cognitively intact patients
31. Prevention and the identification of high risk groups
32. Cognitive therapy for depression in the elderly
33. Life review: Preventing despair in newly relocated nursing home residents: Short and long-term effects
34. The pharmacology of major tranquillizers in the elderly
35. Cognitive performance in geriatric subjects after treatment with antidepressants